United States Biotechnology & Medical Research

Sienna Biopharmaceuticals Inc (SNNAQ)

Track

Ticker: SNNAQ Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Buy 22 Feb 2019
Value US$4,715,224.78 | Price 490.12 | Shares 15,109 (-31.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2019-02-26 2019-02-22 B Purchase
Beddingfield III Frederick

President & CEO
15,109 -31.2%
490.12
US$4,715,225 		15,109 -31.2% 490.12 US$4,715,225
2019-02-26 2019-02-22 B Purchase
ARCH Venture Partners VIII, LLC
Large shareholder
99,522 -12.6%
229.49
US$2,356,459 		99,522 -12.6% 229.49 US$2,356,459
2019-02-26 2019-02-22 B Purchase
ARCH Venture Partners VIII, LLC
Large shareholder
81,044 -44.3%
70.92
US$2,263,519 		81,044 -44.3% 70.92 US$2,263,519
2019-02-26 2019-02-22 B Purchase
ARCH Venture Partners VIII, LLC
Large shareholder
150,000 +5.5%
2.50
US$375,000 		150,000 +5.5% 2.50 US$375,000
2019-02-26 2019-02-22 B Purchase
Leonard Keith R
100,000 +inf%
2.50
US$250,000 		100,000 +inf% 2.50 US$250,000
2019-02-26 2019-02-22 B Purchase
3.2
Burow Kristina
Non-Executive Director
1,865,800 +inf%
2.50
US$4,664,500 		1,865,800 +inf% 2.50 US$4,664,500
2019-02-26 2019-02-22 B Purchase
3.2
Burow Kristina
Non-Executive Director
150,000 +17.0%
2.50
US$375,000 		150,000 +17.0% 2.50 US$375,000
2019-02-26 2019-02-22 B Purchase
3.2
Burow Kristina
Non-Executive Director
150,000 +5.5%
2.50
US$375,000 		150,000 +5.5% 2.50 US$375,000
2019-02-26 2019-02-22 B Purchase
3.4
ARCH Venture Partners X, LLC
Large shareholder
1,865,800 +inf%
2.50
US$4,664,500 		1,865,800 +inf% 2.50 US$4,664,500
2019-02-26 2019-02-22 B Purchase
3.4
ARCH Venture Partners X, LLC
Large shareholder
150,000 +17.0%
2.50
US$375,000 		150,000 +17.0% 2.50 US$375,000
2019-02-26 2019-02-22 B Purchase
3.4
ARCH Venture Partners X, LLC
Large shareholder
150,000 +5.5%
2.50
US$375,000 		150,000 +5.5% 2.50 US$375,000
2019-02-26 2019-02-22 B Purchase
2.8
MORE ROBERT J
100,000 +64.1%
2.50
US$250,000 		100,000 +64.1% 2.50 US$250,000
2018-05-02 2018-04-30 PlS Planned sale Harris Todd

Head of Corporate Development
100 -0.0%
20.00
US$2,000 		100 -0.0% 20.00 US$2,000
2018-04-25 2018-04-25 PlS Planned sale Harris Todd

Head of Corporate Development
300 -0.1%
20.00
US$6,000 		300 -0.1% 20.00 US$6,000
2018-04-25 2018-04-24 PlS Planned sale Harris Todd

Head of Corporate Development
150 -0.0%
20.00
US$3,000 		150 -0.0% 20.00 US$3,000
2018-04-25 2018-04-23 PlS Planned sale Harris Todd

Head of Corporate Development
525 -0.1%
20.00
US$10,500 		525 -0.1% 20.00 US$10,500
2018-04-19 2018-04-18 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
15,810 -2.7%
20.09
US$317,599 		15,810 -2.7% 20.09 US$317,599
2018-04-19 2018-04-17 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
2,201 -0.4%
20.00
US$44,020 		2,201 -0.4% 20.00 US$44,020
2018-04-12 2018-04-10 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
3,779 -0.6%
20.02
US$75,641 		3,779 -0.6% 20.02 US$75,641
2018-04-09 2018-04-09 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
2,824 -0.5%
20.00
US$56,480 		2,824 -0.5% 20.00 US$56,480
2018-04-09 2018-04-05 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
5,386 -0.9%
20.00
US$107,725 		5,386 -0.9% 20.00 US$107,725
2018-03-29 2018-03-29 S Sale MORE ROBERT J
14,429 -7.5%
18.78
US$270,977 		14,429 -7.5% 18.78 US$270,977
2018-03-29 2018-03-28 S Sale MORE ROBERT J
10,000 -4.9%
18.84
US$188,400 		10,000 -4.9% 18.84 US$188,400
2018-03-20 2018-03-19 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
5,876 -1.0%
20.00
US$117,520 		5,876 -1.0% 20.00 US$117,520
2018-03-14 2018-03-12 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
3,452 -0.6%
20.11
US$69,429 		3,452 -0.6% 20.11 US$69,429
2018-03-09 2018-03-09 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
2,438 -0.4%
20.01
US$48,784 		2,438 -0.4% 20.01 US$48,784
2018-03-09 2018-03-08 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
14,530 -2.3%
20.03
US$291,097 		14,530 -2.3% 20.03 US$291,097
2018-03-09 2018-03-07 PlS Planned sale Harris Todd

Head of Corporate Development

Executive Director
3,704 -0.6%
20.00
US$74,080 		3,704 -0.6% 20.00 US$74,080
2017-09-19 2017-09-18 B Purchase FENTON DENNIS M
1,250 +inf%
22.96
US$28,698 		1,250 +inf% 22.96 US$28,698
2017-08-01 2017-08-01 B Purchase Andrews Timothy K.

General Counsel & Secretary
15,000 +inf%
15.00
US$225,000 		15,000 +inf% 15.00 US$225,000
2017-08-01 2017-08-01 B Purchase MAST ERLE T
6,700 +inf%
15.00
US$100,500 		6,700 +inf% 15.00 US$100,500
2017-08-01 2017-08-01 B Purchase Stroehmann Diane

See Remarks
7,000 +5.9%
15.00
US$105,000 		7,000 +5.9% 15.00 US$105,000
2017-08-01 2017-08-01 B Purchase Leonard Keith R
16,700 +inf%
15.00
US$250,500 		16,700 +inf% 15.00 US$250,500
2017-08-01 2017-08-01 B Purchase PETERSON RICHARD D

Chief Financial Officer
7,000 +inf%
15.00
US$105,000 		7,000 +inf% 15.00 US$105,000
2017-08-01 2017-08-01 B Purchase Lizzul Paul F.

Chief Medical Officer
10,000 +11.8%
15.00
US$150,000 		10,000 +11.8% 15.00 US$150,000
Explore more

More insider trading research around Sienna Biopharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America